Hemangioma is the most common type of benign tumorthat arises in the liver. Although rupture and hemorrhageof hepatic hemangioma are rare complications, theycan
AIM To evaluates the effectiveness and safety of thefirst generation, NS3/4A protease inhibitors (PIs) inclinical practice against chronic C virus, especially inp